• LuQi Formula Attenuates Ventricular Remodeling via SPTLC2 In

  2026-05-01

  This study demonstrates that the LuQi Formula (LQF), a traditional Chinese medicine, mitigates ventricular remodeling following myocardial infarction by suppressing SPTLC2-mediated de novo ceramide synthesis. The findings highlight the central role of serine palmitoyltransferase in cardiac lipotoxicity and suggest new directions for sphingolipid metabolism research in cardiovascular disease.

• Tubastatin A: Selective HDAC6 Inhibitor for Advanced Researc

  2026-05-01

  Tubastatin A is a potent, highly selective HDAC6 inhibitor enabling precise modulation of acetylation-dependent cellular processes. Its unique selectivity and workflow flexibility make it invaluable for cancer biology, neuroprotection, and inflammation studies. Benchmarks confirm its reproducible efficacy in both in vitro and in vivo models.

• Dual Src and Tubulin Inhibition: Insights from KX2-391 Disco

  2026-04-30

  This article examines the landmark study detailing the discovery of KX2-391, a dual-action inhibitor targeting both Src kinase and tubulin polymerization. The paper's innovation lies in its unique substrate site targeting approach, leading to enhanced kinase selectivity and potent anticancer activity, with translational implications for oncology and beyond.

• VER 155008: HSP 70 Inhibitor in Proteomic Oncology Research

  2026-04-30

  Explore how VER 155008, a potent HSP 70 inhibitor, advances cancer research through ATPase disruption and proteomic profiling. This article provides unique insights into assay design, translational applications, and the impact of chaperone inhibition on oncology workflows.

• Naloxone Hydrochloride: Advanced Mechanisms and Novel Assay

  2026-04-29

  Delve into how naloxone hydrochloride, a powerful opioid receptor antagonist, enables advanced research on opioid signaling and neural stem cell modulation. This article uniquely bridges mechanistic depth and assay optimization, offering perspectives not found in standard practical guides.

• Thiazolyl N-benzyl Acetamides: Novel Src Kinase Inhibitors a

  2026-04-29

  This study introduces a series of thiazolyl N-benzyl-substituted acetamide derivatives as selective inhibitors of Src kinase, a key player in oncogenic signaling. By focusing on substrate binding site targeting—exemplified by KX2-391—the paper demonstrates structure-activity relationships and highlights the potential of these compounds as anticancer agents, informing the design of next-generation targeted therapies.

• Mild ER Stress Promotes Cadmium Resistance in C. elegans

  2026-04-28

  This study demonstrates that mild activation of the unfolded protein response in the endoplasmic reticulum (UPRER) enhances cadmium resistance in Caenorhabditis elegans. The findings clarify the dose-dependent role of ER stress in detoxification, with implications for research on environmental toxin resistance and protein homeostasis.

• Substance P (SKU B6620): Practical Guide for CNS Research

  2026-04-28

  Substance P (SKU B6620) is formulated for researchers investigating pain transmission, immune response modulation, and inflammation in central nervous system models. Its high purity, water solubility, and specific storage requirements minimize confounding variables in neurokinin-1 pathway studies. This product is not suitable for diagnostic or therapeutic use and should not be used in workflows requiring organic solvent solubility.

• Biotin Azide: Precision Labeling for Bio-Orthogonal Workflow

  2026-04-27

  Biotin Azide empowers researchers to achieve specific, high-efficiency biotin labeling of alkynylated biomolecules using copper-catalyzed click chemistry. This article explores experimental workflows, troubleshooting, and advanced applications—anchored by recent insights into Wnt/β-catenin signaling and cholesterol metabolism in cancer.

• Digoxin in Research: Advanced Insights on Na+/K+ ATPase Inhi

  2026-04-27

  Explore Digoxin as a potent Na+/K+ ATPase pump inhibitor, with in-depth analysis of its mechanistic action, antiviral specificity, and implications for animal models. This article uniquely bridges molecular pharmacology with practical assay guidance for cardiac and virology research.

• Vasopressin Analogues: Therapeutic Versatility and Mechanist

  2026-04-26

  The reviewed study delineates the evolution and expanding therapeutic applications of vasopressin and its analogues, with a focus on lypressin acetate. Through comparative analysis and discussion of modern peptide modifications, the paper highlights both the clinical and research significance of these peptides, particularly in the context of diabetes insipidus and emerging antiviral strategies.

• CHIR 99021 Trihydrochloride: Precision Control of Organoid C

  2026-04-25

  Explore how CHIR 99021 trihydrochloride enables precise modulation of stem cell self-renewal and differentiation in human organoid systems. This article delivers deep mechanistic insight and practical guidance for advanced GSK-3 inhibitor applications in insulin signaling and glucose metabolism research.

• EGCG Nanoparticles Enhance FLASH-RT Efficacy via DNA Damage

  2026-04-24

  This study introduces functionalized self-assembled EGCG nanoparticles (BENPs) as radiosensitizers that significantly boost the antitumor effects of ultra-high dose rate radiotherapy (FLASH-RT). The findings highlight enhanced DNA damage, immune activation, and tumor suppression, offering translational potential for optimizing cancer radiotherapy strategies.

• Digoxin as a Na+/K+ ATPase Pump Inhibitor: Applied Protocols

  2026-04-24

  Digoxin empowers research teams with dual functionality: precise cardiac contractility modulation and targeted inhibition of chikungunya virus infection in vitro. This article unlocks stepwise workflows, optimization strategies, and troubleshooting tips for leveraging high-purity Digoxin from APExBIO in both cardiovascular and antiviral research models.

• MEK1/2-c-Myc-Max Axis Prevents Polycomb Repression of TERT i

  2026-04-23

  This study reveals that MEK1/2 kinases and the c-Myc-Max complex cooperatively prevent polycomb-mediated repression of TERT, ensuring telomerase activity in human pluripotent stem cells. The findings clarify a key mechanism underlying telomere maintenance and suggest new experimental avenues for dissecting telomerase regulation.

14815 records 1/988 page Next 12345 下5页 Last page